US Patent Issued to Cipla on Aug. 12 for "Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor" (Indian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,784, issued on Aug. 12, was assigned to Cipla Ltd. (Maharashtra, India).

"Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor" was invented by Geena Malhotra (Mumbai, India), Venkata Srinivas Pullela (Bangalore, India), Srinivas Laxminarayan Pathi (Bangalore, India), Ramanaiah Chennuru (Andhra Pradesh, India), Ramesh Devarapalli (Andhra Pradesh, India) and Ashok Mithun (Bangalore, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses novel crystalline polymorphic forms of Acalabrutinib, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms the...